NASDAQ:REVB Revelation Biosciences Q1 2026 Earnings Results & Report $3.97 +0.09 (+2.27%) Closing price 03:58 PM EasternExtended Trading$3.93 -0.04 (-1.03%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Revelation Biosciences missed analyst earnings expectations in its Q1 2026 results, released May 7, 2026. The company reported EPS of -$18.97 versus the -$8.05 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateMay 7, 2026TimeBefore Market OpensConference Call8:00 AM ET Revelation Biosciences EPS ResultsActual EPS-$18.97Consensus EPS -$8.05Beat/MissMissed by -$10.92One Year Ago EPSN/AEPS Beat Rate2 of last 5 quartersRevelation Biosciences Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Revelation Biosciences Q1 2026 Earnings FAQ Did Revelation Biosciences beat earnings estimates for Q1 2026? Revelation Biosciences (NASDAQ:REVB) reported earnings of -$18.97 per share for Q1 2026, missing the consensus estimate of -$8.05. The report was announced on Thursday, May 7, 2026. Revelation Biosciences Earnings HeadlinesRevelation Biosciences Announces Accelerated Gemini Development Plan and Strategic Partnership InitiativesNovember 16 at 10:00 AM | marketscreener.comMResearch Analysts Offer Predictions for REVB FY2026 EarningsNovember 15 at 10:31 AM | americanbankingnews.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.November 18 at 1:00 AM | Porter & Company (Ad)Analysts Set Expectations for REVB Q1 EarningsNovember 14, 2026 | americanbankingnews.comRevelation Biosciences, Inc. Announces Financial Results For the Three and Nine Months Ended September 30, 2026November 5, 2026 | businesswire.comRevelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026October 16, 2026 | finance.yahoo.comSee More Revelation Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Revelation Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Revelation Biosciences and other key companies, straight to your email. Email Address About Revelation BiosciencesRevelation Biosciences (NASDAQ:REVB) is a clinical-stage biotechnology company developing treatments that target the innate immune system. Its research focuses on potential therapies for infectious and other diseases. The company’s lead program, Gemini, is an intranasal formulation of an immune-stimulating compound designed to activate Toll-like receptor 4. Revelation has investigated Gemini as a potential way to help prevent or treat respiratory infections. Revelation’s work is centered on developing its therapeutic candidates; the company has not established a broad commercial product portfolio. Its programs remain in development.View Revelation Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes ShapeGeneral Motors Faces a Cost Squeeze as Factory Automation Takes Center StageNVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?5 Consumer Discretionary Plays Showing Strength During the Tech Sell-OffAMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Viking’s Low-Water Miss Looks Like a Buy-the-Dip OpportunityDisney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.